What is the price of Roche Holding AG (RO)

The price of Roche Holding AG (RO) is $484.33

What is the market cap of Roche Holding AG (RO)

The market cap of Roche Holding AG (RO) is $379.69B

Roche Holding AG (RO) P/S Ratio

Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.

Year	P/S Ratio	Change
Not enough data for the provided dates.

Year

P/S Ratio

Change

Not enough data for the provided dates.

Company	P/S Ratio	P/S Ratio Difference	Country
Eli Lilly and Company LLY.US	13.45	222.49%	US
Johnson & Johnson JNJ.US	6.55	57.15%	US
AbbVie Inc. ABBV.US	7.18	72.19%	US
Merck & Co., Inc. MRK.US	5.39	29.18%	US
Novartis AG NOVN.SW	5.52	32.37%	CH

Company

P/S Ratio

P/S Ratio Difference

Country

Eli Lilly and Company

LLY.US

13.45

222.49%

Johnson & Johnson

JNJ.US

6.55

57.15%

AbbVie Inc.

ABBV.US

7.18

72.19%

Merck & Co., Inc.

MRK.US

5.39

29.18%

Novartis AG

NOVN.SW

5.52

32.37%

Roche Holding AG

RO

Category